These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. TNF-alpha is an important pathogenic factor contributing to reactivation of cytomegalovirus in inflamed mucosa of colon in patients with ulcerative colitis: lesson from clinical experience. Nakase H; Chiba T Inflamm Bowel Dis; 2010 Apr; 16(4):550-1. PubMed ID: 19637380 [No Abstract] [Full Text] [Related]
25. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids. Yamamoto-Furusho JK; Uzcanga LF Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257 [TBL] [Abstract][Full Text] [Related]
26. Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis. Fratila OC; Craciun C J Gastrointestin Liver Dis; 2010 Jun; 19(2):147-53. PubMed ID: 20593047 [TBL] [Abstract][Full Text] [Related]
27. Treating Ulcerative Colitis During Pregnancy: Evidence of Materno-Fetal Transfer of Golimumab. Benoit L; Mir O; Berveiller P J Crohns Colitis; 2019 Apr; 13(5):669-670. PubMed ID: 30445579 [No Abstract] [Full Text] [Related]
31. In the case of nonresponse to steroids, what is the second level of treatment in ulcerative colitis? Caprilli R Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S226-7. PubMed ID: 18816754 [No Abstract] [Full Text] [Related]
32. Is keeping the colon the ultimate marker of success in ulcerative colitis? Nguyen GC; Prather CM Gastroenterology; 2009 Oct; 137(4):1204-6. PubMed ID: 19717125 [No Abstract] [Full Text] [Related]
33. The effect of controlling inflammatory activity in the colon on the response to infliximab of autoimmune haemolytic anaemia associated with ulcerative colitis. Leo-Carnerero E; Araujo-Míguez A; Trigo-Salado C; De-la-Cruz-Ramírez MD; Herrera-Justiniano JM; Márquez-Galán JL Rev Esp Enferm Dig; 2014 Apr; 106(4):295-6. PubMed ID: 25075665 [No Abstract] [Full Text] [Related]
34. Use of infliximab in pregnancy. Mahadevan U; Kane S Am J Gastroenterol; 2010 Jan; 105(1):219; author reply 219-20. PubMed ID: 20054309 [No Abstract] [Full Text] [Related]
35. Colectomy rate in acute severe ulcerative colitis in the infliximab era. Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316 [TBL] [Abstract][Full Text] [Related]
37. Infliximab-induced reactivated Langerhan's cell histiocytosis in a patient with ulcerative colitis. Rodríguez HN; García I; Alba A; Igea F Inflamm Bowel Dis; 2009 Sep; 15(9):1286-7. PubMed ID: 18942740 [No Abstract] [Full Text] [Related]
38. Infliximab for the treatment of ulcerative colitis. Eshuis EJ; Bemelman WA; Stokkers PC Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):219-29. PubMed ID: 19485804 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of infliximab in Brazilian children and adolescents with Crohn disease and ulcerative colitis according to clinical manifestations, activity indices of inflammatory bowel disease, and corticosteroid use. Tiemi J; Komati S; Sdepanian VL J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):628-33. PubMed ID: 20386321 [TBL] [Abstract][Full Text] [Related]
40. Medical treatment and management of severe ulcerative colitis. Rizzello F; Campieri M; Tambasco R; Straforini G; Brugnera R; Poggioli G; Gionchetti P Dig Liver Dis; 2008 Jul; 40 Suppl 2():S280-4. PubMed ID: 18599001 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]